Basel, 29 April 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation for the VENTANA® TROP2 (EPR20043) ...

The Board of Directors of Financière de Tubize appoints Bruno Holthof as new Chair ...

Allschwil, Switzerland – April 29, 2025 Idorsia Ltd (SIX: IDIA) today announced the publication of “ Effect of daridorexant on nighttime wakefulness and next-morning sleepiness: assessing the ...

Statistical evidence from meta-analysis of VIVIAD and VIVA-MIND enables efficient design of Phase 2b study in diabetic kidney disease (DKD), ideally suited to evaluate varoglutamstat in the intended ...

Blurriness & Eye Focus: Today’s screen-heavy lifestyle can often stress the eyes, sometimes leading to mild blurriness and difficulty focusing. Lumineye’s sublingual nano-formulation is designed to ...

FDA granted an accelerated approval for Vanrafia for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression. Vanrafia can be ...

Pratteln, Switzerland, April 29, 2025 – Santhera Pharmaceuticals (SIX: SANN) today published the invitation to its Annual General Meeting (AGM), which will be held on May 20, 2025, at 10:00 CEST at ...

When blood sugar spikes and crashes, it can cause feelings of fatigue, irritability, and mood swings. Keeping blood sugar ...

Sheding Weight, not only helps you shed weight, but Mitolyn is unique as it naturally and totally enhances your health, ...

Increase in semen volume: after consuming a single dosage of Volume Pills, men might begin to experience enhanced sexual ...

Chardan Capital’s Trending Issues in Drug Development Conference – April 29, 2025 (Virtual) ...

The data presented at the AACR Annual Meeting show that amezalpat reduced tumor promoting immunosuppression by M2 macrophages and T regulatory cells resulting in immune activation. These data support ...